EMEA-002668-PIP01-19
Key facts
| Active substance |
5%-Δ9-tetrahydrocannabinol standardised Cannabis extract
|
| Therapeutic area |
Pain
|
| Decision number |
P/0077/2020
|
| PIP number |
EMEA-002668-PIP01-19
|
| Pharmaceutical form(s) |
Oral solution
|
| Condition(s) / indication(s) |
Treatment of chronic pain
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Vertanical GmbH
E-mail: A.Buchner@futrue.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|